Federal Auditors Flag $186B in Improper Payments as Hospital Lobby Spends $116M

Public records show federal agencies lost track of $186 billion in a single fiscal year while the hospital industry spent at least $116 million lobbying the bodies that set payment and audit rules.

The single most documented fact in the federal payment integrity record is this: U.S. government agencies disbursed an estimated $186 billion in improper payments in Fiscal Year 2025, up roughly $24 billion from the prior year, according to GAO Report GAO-26-108694 released in April 2026. That cumulative figure, running back to FY2003, now stands at approximately $3 trillion — and the GAO itself acknowledges the actual total 'may be much higher' because the audit reviewed only 64 programs across 15 agencies, not the full universe of federal spending. The single largest sector sitting inside that number is federally funded healthcare, where Medicaid and Medicare hospital reimbursement flows represent the highest-volume, highest-dollar payment streams in the federal government.

The Medicaid portion of the problem carries its own contested arithmetic. The Centers for Medicare and Medicaid Services officially reported $543 billion in Medicaid improper payments from 2015 through 2024. The Paragon Institute, a health policy research organization, published an analysis arguing the true figure is approximately $1.086 trillion — roughly double — because the Obama and Biden administrations excluded eligibility-based errors from the reported totals. The underlying methodological point — that eligibility errors were excluded from the Payment Error Rate Measurement program — is documented in CMS's own PERM technical records and is not solely a partisan claim, though Paragon's specific doubling methodology warrants independent verification against CMS source data. At either number, the scale of unrecovered public funds flowing through hospital reimbursement channels is without precedent in the domestic budget.

A specific mechanism connecting hospitals directly to improper Medicaid disbursements is hospital presumptive eligibility, under which hospitals may enroll individuals into Medicaid based on a limited income questionnaire without verification. The Foundation for Government Accountability documented in 2018 that 70 percent of individuals enrolled by hospitals under this mechanism were subsequently found ineligible or had their information go unverified. The provided public records contain no updated figure for the COVID-19 continuous enrollment period of March 2020 through March 2023, during which eligibility verification requirements were relaxed nationwide — a gap that represents a potentially significant unquantified exposure in the public record. When hospitals enroll ineligible individuals and receive Medicaid reimbursement for services rendered to those individuals, the audit question becomes whether states pursue recovery and whether hospitals repay. Available records do not specify recovery rates in presumptive eligibility cases.

The state level provides a concrete, named case study. A federal Inspector General audit reported in January 2026 alleged $46 million in improper payments through MaineCare, Maine's Medicaid program, according to Spectrum Local News. State Senator Mike Tipping, Democrat of Orono, stated publicly that he wanted 'the facts on this' before drawing conclusions. Maine House Republicans characterized the findings as confirmation of 'widespread fraud, waste and abuse within MaineCare' that 'can no longer be dismissed or hidden.' The Maine legislature's relevant committee planned to call DHHS fraud investigators and separately asked the Department of Administrative and Financial Services to explain its procurement process — a signal that the audit touched potential procurement irregularities beyond pure payment errors. The specific federal IG office that conducted the audit is not identified in available public records; given that MaineCare is a Medicaid program, HHS-OIG is the most likely origin, but this remains unconfirmed in the public record. No final audit disposition, CMS response, or recovery timeline has been published as of the date of this analysis.

Against this backdrop of audit findings and unrecovered funds sits the hospital industry's investment in federal policy influence. A peer-reviewed study published in PMC — PubMed Central, a service of the National Library of Medicine — documents $116 million in federal lobbying expenditures by hospitals over the study period. The research finds that this political spending is 'not distributed equally across hospital types,' that expenditures are 'concentrated among large, well-resourced systems,' and that lobbying is 'often channeled through a relatively small set of professional lobbying firms with established connections to policymakers.' The PMC study does not specify the exact time period covered by the $116 million figure, which prevents per-year calculation and is a critical contextual gap in the available record. What the study does establish structurally is that the hospital entities with the greatest Medicaid and Medicare payment volumes — and therefore the greatest audit exposure — are also the entities with the greatest political influence over the agencies and congressional committees that set payment policies and audit standards.

The GAO's own audit function under the Lobbying Disclosure Act, mandated by the Honest Leadership and Open Government Act of 2007, selects lobbying registrants for compliance review on a randomized basis and issues findings each spring. Individual firms are not publicly singled out in those reports. The PERM program, which measures Medicaid improper payments, operates on a three-year rolling cycle across all states — meaning a payment error at a specific hospital may not be measured, reported, or actioned for up to three years after the disbursement. These structural features of the accountability system — randomized rather than risk-targeted lobbying audits, multi-year measurement lags in Medicaid error detection, and the exclusion of eligibility errors from official improper payment totals during at least two administrations — collectively create conditions under which large payment volumes move with limited real-time accountability.

What the public record does not yet contain is a single integrated database connecting specific improper payment audit findings to specific hospital recipients, recovery actions taken or not taken, and the lobbying expenditures of those same institutions before the bodies responsible for audit policy. The GAO-26-108694 report establishes the $186 billion aggregate but does not map payments to named hospital systems. The PMC lobbying study identifies the $116 million total but — in its available excerpt — does not name the specific systems or lobbying firms that account for it. The MaineCare audit identifies a $46 million exposure but has not produced a final disposition in the public record. The instrument that would close these gaps is a combination of: a Freedom of Information Act request to HHS-OIG for the complete MaineCare audit finding and any recovery correspondence; a cross-reference of Senate Lobbying Disclosure Act filings at lda.senate.gov to identify which hospital systems and associations account for the $116 million and which congressional committees and executive branch offices they contacted; and a CMS FOIA request for hospital-specific PERM findings and recovery correspondence for FY2020 through FY2025. Until those records are assembled and published, the connection between who received the money, who lobbied for the rules governing that money, and what was recovered remains a gap in the public interest account.